| 英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
|---|---|---|---|---|---|---|
|
MK-2461
|
917879-39-1 |
MK-2461
|
|
C24H25N5O5S |
495.557 | |
|
Mitoxantrone
|
65271-80-9 |
米托蒽醌
|
米托恩醌;盐酸米托蒽醌 ;1,4-二羟基-5,8-二[[2-[(2-羟基乙基)氨基]乙基]氨基]蒽-9,10-二酮;米拖蒽醌;米托蒽醌(米托恩醌、米拖蒽醌);米托蒽醌;1,8-双[[2-[(2-羟乙基)氨基]乙基]氨基]-9,11-蒽醌
|
C22H28N4O6 |
444.48 | 1533716-785-6 |
|
Mezlocillin Sodium
|
42057-22-7 |
美洛西林钠
|
|
C21H24NAN5O8S2 |
561.56 | 255-640-5 |
|
LY500307
|
533884-09-2 |
Erteberel (LY500307)
|
(3AS,4R,9BR)-1,2,3,3A,4,9B-六氢-4-(4-羟基苯基)环戊并[C][1]苯并吡喃-8-醇;芬克罗酮;CS-897
|
C18H18O3 |
282.33372 | |
|
LY2584702
|
1082949-67-4 |
LY-2584702
|
CS-1752
|
C21H19F4N7 |
445.4221 | |
|
LY2228820
|
862507-23-1 |
5-[2-(叔丁基)-4-(4-氟苯基)-1H-咪唑-5-基]-3-(2,2-二甲基丙基)-3H-咪唑并[4,5-B]吡啶-2-胺甲磺酸盐
|
LY2228820 (Ralimetinib);Ralimetinib 2MsOH(LY2228820);LY2228820;5-[2-(1,1-DiMethylethyl)-5-(4-fluorophenyl)-1H-iMidazol-4-yl]-3-(2,2-diMethylpropyl)-3H-iMidazo[4,5-b]pyridin-2-aMine DiMethanesulfonate;LY2228820(LY-2228820);LY2228820 2MsOH;LY2228820 diMesylate;5-[2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine methanesulfonate
|
612.22 |
C26H37FN6O6S2 | |
|
LEE011
|
1211441-98-3 |
LEE011
|
瑞柏司可里布;LEE011 瑞柏司可里布;LEE011 瑞柏司可里布 50MG
|
C23H30N8O |
434.5373 | 1592732-453-0 |
|
LDN193189 Hydrochloride
|
1062368-62-0 |
LDN-193189 HCl
|
4-(6-(4-(哌嗪-1-基)苯基)吡唑并[1,5-A]嘧啶-3-基)喹啉盐酸盐;CS-1451;4-[6-[4-(1-哌嗪基)苯基]吡唑并[1,5-A]嘧啶-3-基]喹啉盐酸盐;4-(6-(4-(哌嗪-1-基)苯基)吡唑并[1,5-A]嘧;LDN193189 盐酸盐,一种选择性的 BMP I 型受体激酶抑制剂;LDN-193189 HCL;LDN 193189 HCL
|
C25H23ClN6 |
442.94332 | |
|
KRN 633
|
286370-15-8 |
N-[2-氯-4-[(6,7-二甲氧基-4-喹唑啉基)氧基]苯基]-N'-丙基脲
|
KRN633;KRN-633;KRN 633;N-[2-氯-4-[(6,7-二甲氧基-4-喹唑啉基)氧基]苯基]-N'-丙基脲;CS-463;KRN 633;KRN-633
|
C20H21N4O4Cl |
416.85814 | |
|
IU1
|
314245-33-5 |
1-[1-(4-FLUOROPHENYL)-2,5-DIMETHYL-1H-PYRROL-3-YL]-2-(1-PYRROLIDINYL)ETHANONE;IU1
|
IU1;IU-1;IU 1;1-[1-(4-FLUOROPHENYL)-2,5-DIMETHYL-1H-PYRROL-3-YL]-2-(1-PYRROLIDINYL)ETHANONE;IU1;1-[1-(4-氟苯基)-2,5-二甲基-1H-吡咯-3-基]-2-(1-吡咯烷基)乙酮
|
C18H21FN2O |
300 | |
|
ISRIB (trans-isomer)
|
1597403-47-8 |
ISRIB(TRANS-ISOMER) 抑制剂
|
ISRIB (TRANS-ISOMER)>98%;ISRIB(TRANS-ISOMER)抑制剂
|
C22H24Cl2N2O4 |
451.34296 | |
|
IMD 0354
|
978-62-1 |
N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺
|
IMD 0354;IMD-0354;IKK-2 INHIBITOR V;IMD 0354;IMD0354;N-[3,5-双(三氟甲基)苯基]-5-氯-2-羟基苯甲酰胺;IMD-0354,一种合成的选择性NF-KB 抑制剂
|
C15H8NO2F6Cl |
383.67292 | |
|
IKK-16
|
873225-46-8 |
IKK-16,选择性IKK抑制剂
|
IKK-16,选择性IKK抑制剂;[4-[(4-苯并[B]噻吩-2-基-2-嘧啶)氨基]苯基][4-(1-吡咯烷)-1-哌啶基]-甲酮;CS-1847;IKK16;IKK-16;IKK INHIBITOR VII;1-[4-[(4-苯并[B]噻吩-2-基-2-嘧啶基)氨基]苯甲酰基]-4-(1-吡咯烷基)哌啶
|
C28H29N5OS |
483.62776 | |
|
Ibuprofen Lysine (NeoProfen)
|
57469-77-9 |
布洛芬赖氨酸盐
|
l-lysine mono[4-isobutyl-alpha-methylbenzeneacetate];IBUPROFEN LYSINE;IBUPROFEN LYSINE 99+;IbuprofenLysine/Lysinate;IbuprofenLysineEdmf;Lysinate;Ibuprofen, L-lysine salt;Ibuprofen-lysine complex
|
C13H18O2.C6H14N2O2 |
352.47 | 260-751-7 |
|
GDC-0152
|
873652-48-3 |
GDC-0152
|
GDC-0152; GDC0152; GDC 0152.;GDC0152;GDC 0152.;(S)-1-((S)-2-环己基-2-((S)-2-(甲基氨基)丙酰胺基)乙酰基)-N-(4-苯基-1,2,3-噻二唑-5-基)吡咯烷-2-甲酰胺
|
C25H34N6O3S |
498.6486 | |
|
EX 527
|
49843-98-3 |
EX-527
|
EX 527;EX527;6-氯-2,3,4,9-四氢-1H-咔唑-1-甲酰胺;6-氯-2,9-四氢-1H-咔唑-1-羧酰胺;司来司他;SELISISTAT;EX 527;EX527;SEN0014196
|
C13H13CLN2O |
248.71 | |
|
GS-9973
|
1229208-44-9 |
Entospletinib (GS-9973)
|
6-(1H-吲唑-6-基)-N-[4-(4-吗啉基)苯基]咪唑并[1,2-A]吡嗪-8-胺;GS-9973;GS 9973 ;CS-1602;脾脏酪氨酸激酶(SYK)抑制剂
|
C23H21N7O |
411.45914 | -0 |
|
EMbelin
|
550-24-3 |
恩贝酸/恩贝灵
|
恩贝酸>98%;恩贝酸;恩贝灵;恩貝酸;酸藤子酚;恩贝酸;蒽贝素;信筒子素;蒽贝素(酸藤子酚)
|
C17H26O4 |
294.38594 | 208-979-8 |
|
Dorsomorphin 2Hydrochloride
|
1219168-18-9 |
BML-275
|
6-[4-(2-PIPERIDIN-1-YLETHOXY)PHENYL]-3-PYRIDIN-4-YLPYRAZOLO[1,5-A]PYRIMIDINE;DIHYDROCHLORIDE;BML-275;COMPOUND C;BML275;BML 275;CS-1883;6-[4-[2-(1-哌啶基)乙氧基]苯基]-3-(4-吡啶基)吡唑并[1,5-A]嘧啶二盐酸盐;BML-275 HCL,物质C盐酸盐;BML-275(2HCL);BML-275;COMPOUND C;BML275;BML 275;BML-275 DIHYDROCHLORIDE;COMPOUND C DIHYDROCHLORIDE;BML275 DIHYDROCHLORIDE;BML 275 DIHYDROCHLORIDE;DORSOMORPHIN (COMPOUND C)2HCL
|
C24H27Cl2N5O |
472.41008 | |
|
DMXAA (ASA404)
|
117570-53-3 |
2,5-己酮可可碱
|
伐地美生;5,6-二甲基-9-氧-9-氢-氧杂蒽-4-乙酸;CS-1975;5-己酮可可碱;2,5-己酮可可碱VADIMEZAN(DMXAA,ASA-204);2-(5,6-二甲基-9-氧代占吨-4-基)乙酸;5,6-二甲基-9H-氧杂蒽-9-酮-4-乙酸;2,5-己酮可可碱
|
C17H14O4 |
282.29066 | 700-141-4 |
药智官方微信
药智官方微博
